10 research outputs found
In Vitro and In Vivo Evidence that Thrombospondin-1 (TSP-1) Contributes to Stirring- and Shear-Dependent Activation of Platelet-Derived TGF-Ξ²1
Thrombospondin 1 (TSP-1), which is contained in platelet Ξ±-granules and released with activation, has been shown to activate latent TGF-Ξ²1 in vitro, but its in vivo role is unclear as TSP-1-null (Thbs1β/β) mice have a much less severe phenotype than TGF-Ξ²1-null (Tgfb1β/β) mice. We recently demonstrated that stirring and/or shear could activate latent TGF-Ξ²1 released from platelets and have now studied these methods of TGF-Ξ²1 activation in samples from Thbs1β/β mice, which have higher platelet counts and higher levels of total TGF-Ξ²1 in their serum than wild type mice. After either two hours of stirring or shear, Thbs1β/β samples demonstrated less TGF-Ξ²1 activation (31% and 54% lower levels of active TGF-Ξ²1 in serum and platelet releasates, respectively). TGF-Ξ²1 activation in Thbs1β/β mice samples was normalized by adding recombinant human TSP-1 (rhTSP-1). Exposure of platelet releasates to shear for one hour led to near depletion of TSP-1, but this could be prevented by preincubating samples with thiol-reactive agents. Moreover, replenishing rhTSP-1 to human platelet releasates after one hour of stirring enhanced TGF-Ξ²1 activation. In vivo TGF-Ξ²1 activation in carotid artery thrombi was also partially impaired in Thbs1β/β mice. These data indicate that TSP-1 contributes to shear-dependent TGF-Ξ²1 activation, thus providing a potential explanation for the inconsistent in vitro data previously reported as well as for the differences in phenotypes of Thbs1β/β and Tgfb1β/β mice
Stirring increases TGF-Ξ²1 activation in platelet releasates from WT mice more than from <i>Thbs1</i><i><sup>β</sup></i><sup><i>/</i><i>β</i></sup> mice and recombinant human TSP-1 corrects the defect.
<p>(A) Thrombin-induced aggregation of washed platelets from WT and <i>Thbs1<sup>β/β</sup></i> mice. (B, C, D) Platelet releasates were either left unstirred (US) at 37Β°C or stirred (S) at 1,200 rpm for 120 min and then total (B) and active (C, D) TGF-Ξ²1 were measured. (B) The decline of total TGF-Ξ²1 in stirred versus unstirred platelet releasates was similar in WT and <i>Thbs1<sup>β/β</sup></i> mice. (C, D) Active TGF-Ξ²1 increased more in WT than <i>Thbs1<sup>β/β</sup></i> mice [pβ=β0.004 (absolute values) and pβ=β0.005 (percentages of total TGF-Ξ²1) for interaction by ANOVA]. The final values were also higher in WT vs <i>Thbs1<sup>β/β</sup></i> mice (pβ=β0.005 and pβ=β0.008 by t-test). (E) Immunoblotting of platelet releasates obtained from WT or TSP-1 null mice demonstrated absence of TSP-1 protein in a <i>Thbs1<sup>β/β</sup></i> mouse (lane 4); addition of 20 Β΅g/mL of rhTSP-1 protein to the <i>Thbs1<sup>β/β</sup></i> mouse sample (lane 2) achieved a TSP-1 level similar to those in a WT mouse sample (lane 1) and a human platelet releasate (lane 3). (F) Adding rhTSP-1 (+) versus BSA (β) corrected the defect in stirring-induced activation of TGF-Ξ²1 in <i>Thbs1<sup>β/β</sup></i> mice.</p
TSP-1 is required for <i>in vivo</i> time-dependent activation of TGF-Ξ²1 in platelet-rich thrombi.
<p>Thrombosis was induced in the carotid arteries of WT or <i>Thbs1<sup>β/β</sup></i> mice by exposure to either 8% FeCl<sub>3</sub> (filled triangles, nβ=β20) or 20% FeCl<sub>3</sub> (open circles, nβ=β36) for 3 min. At either 5 min or 120 min after the vessel became completely occluded, approximately 4 mm carotid arterial segments were excised. The thrombi from the vessels were removed and extracts from them were prepared for analysis of active and total TGF-Ξ²1. Since the effects of 20% and 8% FeCl<sub>3</sub> were similar, the data were pooled. Active TGF-Ξ²1 levels expressed as a percentage of total TGF-Ξ²1 were similar after 5 min. The values of active TGF-Ξ²1 increased with time after occlusion in WT but not in <i>Thbs1<sup>β/β</sup></i> mice (pβ=β0.0024 for interaction by ANOVA). Moreover, the values in the 120 min samples of WT mice were higher than those in <i>Thbs1<sup>β/β</sup></i> mice (pβ=β0.041 by t-test).</p
Sera from <i>Thbs1<sup>β/β</sup></i> mice have reduced ability to undergo activation of TGF-Ξ²1 by stirring or shear.
<p>(A) Immunoblots of WT and <i>Thbs1<sup>β/β</sup></i> mice sera demonstrate absence of TSP-1 in the <i>Thbs1<sup>β/β</sup></i> mice. (B, C, D) Sera from WT (nβ=β23) and <i>Thbs1<sup>β/β</sup></i> (nβ=β23) mice were stirred (S) at 1,200 rpm or left unstirred (US) for 120 min at 37Β°C and then total (B) and active (C, D) TGF-Ξ²1 were measured; the latter was expressed either as an absolute value (ng/mL) (C) or as a percentage of total TGF-Ξ²1 (D). Levels of active TGF-Ξ²1 increased less in <i>Thbs1<sup>β/β</sup></i> than WT mice with stirring [pβ=β0.057 (absolute values) and pβ=β0.016 (percentages of total TGF-Ξ²1) for interaction by ANOVA]. The post-stirring values were also higher in WT than <i>Thbs1<sup>β/β</sup></i> mice [pβ=β0.19 (absolute values) and pβ=β0.001 (percentages of total TGF-Ξ²1) by t-test]. (E, F) Sera from WT (nβ=β10) or <i>Thbs1<sup>β/β</sup></i> (nβ=β10) mice were either incubated at 37Β°C (β) or subjected to shear (+) at 1,800 s<sup>β1</sup> at 37Β°C for 120 min. Active TGF-Ξ²1 increased more in WT mice, both in terms of absolute values (pβ=β0.18 by t-test) (E) and as percentages of total TGF-Ξ²1 (pβ=β0.039 by t-test) (F).</p
WT, wild type; <i>Thbs1<sup>β/β</sup></i>, TSP-1-null; WBC, white blood count; RBC, red blood cell count; HCT, hematocrit; MCV, mean corpuscular volume; PLT, platelets; MPV, mean platelet volume; fL, femtoliters.
*<p>p<0.005 vs WT.</p
Shear depletes TSP-1 via a thiol-dependent mechanism.
<p>(A) The proteins in human platelet releasates were labeled with MPB (100 Β΅M) for 30 min either before (β) or after (+) shear for 2 hours. The labeled proteins were either analyzed directly (left two lanes) or after affinity-purification using Streptavidin-coupled beads (right two lanes). Shearing led to a dramatic decrease in intensity of the HRP reaction in select regions. (B) One of the MPB-labeled proteins (boxed) that was most affected by shearing was identified as TSP-1 by LC-MS/MS analysis. (C) Platelet releasates were passed through either a control-Sepharose column (Con) or a thiol-Sepharose column (Thiol) and then labeled with MPB. Depletion of thiol-reactive proteins by the column was analyzed by reaction of the separated proteins with Streptavidin (left panel) and depletion of TSP-1 protein was measured by immunoblotting with an anti-TSP-1 antibody (right panel). Nearly all of the proteins that labeled with MPB from the control column were not labeled after passage through the thiol-Sepharose column. (D) Effect of increasing time of exposure to shear on depletion of TSP-1 from platelet releasates. MPB labeling of TSP-1 was concordantly reduced with the loss to TSP-1 protein during shear as judged by reaction with Streptavidin-HRP (left panel) and immunoblotting with an anti-TSP-1 antibody (middle panel). TGF-Ξ²1 depletion was much less pronounced as judged by immunoblotting with an anti-TGF-Ξ²1 antibody (right panel). (E) Addition of MPB (100 Β΅M) before shear partially prevented the loss of TSP-1 protein as shown by immunoblotting with an anti-TSP-1 antibody. Addition of the other thiol-reactive reagents, BMCC (F) or NEM (G), similarly protected against loss of TSP-1. Vertical lines in (F) indicate deletion of intermediate lanes from the same gel.</p